다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Moleculin Biotech Inc (MBRX)
Moleculin Biotech Inc (MBRX) 뉴스

MBRX

Moleculin Biotech (MBRX)

Moleculin Biotech Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MBRX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/16	21:32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/16	21:32	PR Newswire (US)	Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/15	21:38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/15	21:38	PR Newswire (US)	Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/15	05:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/13	23:53	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/13	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/13	20:30	PR Newswire (US)	Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/11	05:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/09	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/09	21:30	PR Newswire (US)	Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/08	21:45	PR Newswire (US)	Moleculin to Report First Quarter 2024 Financial Results on May 10, 2024 and Host Conference Call and Webcast	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/08	21:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/08	05:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/07	21:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/07	21:55	PR Newswire (US)	Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim Subject Data	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/02	22:00	PR Newswire (US)	Moleculin to Host Virtual AML Clinical Day Featuring Internationally Renowned Clinician, Martin S. Tallman, MD, on May 7, 2024	NASDAQ:MBRX	Moleculin Biotech Inc
2024/05/01	21:50	PR Newswire (US)	Moleculin Announces Formation of Scientific Advisory Board to Support Development of Annamycin	NASDAQ:MBRX	Moleculin Biotech Inc
2024/04/18	21:30	PR Newswire (US)	European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)	NASDAQ:MBRX	Moleculin Biotech Inc
2024/04/10	21:30	PR Newswire (US)	Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties	NASDAQ:MBRX	Moleculin Biotech Inc
2024/03/28	23:45	PR Newswire (US)	Moleculin to Present at the MedInvest Biotech & Pharma Investor Conference	NASDAQ:MBRX	Moleculin Biotech Inc
2024/03/27	22:25	PR Newswire (US)	Moleculin to Participate in the Virtual Investor Lunch Break: The Moleculin Opportunity	NASDAQ:MBRX	Moleculin Biotech Inc
2024/03/27	22:05	PR Newswire (US)	Moleculin Announces U.S. Patent Issue Notification for Annamycin Targeting Unmet Need in AML	NASDAQ:MBRX	Moleculin Biotech Inc
2024/03/25	20:30	PR Newswire (US)	Moleculin Announces Positive Interim Data in Annamycin MB-106 Phase 1B/2 AML Trial	NASDAQ:MBRX	Moleculin Biotech Inc
2024/03/23	05:05	PR Newswire (US)	Moleculin Reports Full Year 2023 Financial Results	NASDAQ:MBRX	Moleculin Biotech Inc
2024/03/20	20:30	PR Newswire (US)	Moleculin to Report Full Year 2023 Financial Results on March 22, 2024 and Host Conference Call and Webcast	NASDAQ:MBRX	Moleculin Biotech Inc
2024/03/20	20:15	IH Market News	JPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest News	NASDAQ:MBRX	Moleculin Biotech Inc
2024/03/20	05:30	PR Newswire (US)	Moleculin Announces Reverse Stock Split	NASDAQ:MBRX	Moleculin Biotech Inc
2024/03/12	22:05	PR Newswire (US)	Moleculin to Present at the 36th Annual ROTH Conference	NASDAQ:MBRX	Moleculin Biotech Inc
2024/02/29	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBRX	Moleculin Biotech Inc

검색 관련기사 보기:NASDAQ:MBRX

1 2 3 4 5 6 7 8 9 10 다음 >>

Deutsche Telekom (QX)

BNP Paribas (QX)

Financial Select Sector

JP Morgan Chase

Health Care Select Sector

US Dollar vs Yen

US Dollar vs Sterling

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관